Skylands Capital LLC Holds Stake in Agilent Technologies Inc (A)

Skylands Capital LLC held its stake in Agilent Technologies Inc (NYSE:A) during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 9,650 shares of the medical research company’s stock at the end of the first quarter. Skylands Capital LLC’s holdings in Agilent Technologies were worth $510,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of A. Municipal Employees Retirement System of Michigan raised its stake in Agilent Technologies by 0.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 10,410 shares of the medical research company’s stock worth $490,000 after buying an additional 50 shares during the period. Quadrant Capital Group LLC raised its stake in Agilent Technologies by 0.9% in the first quarter. Quadrant Capital Group LLC now owns 5,470 shares of the medical research company’s stock worth $284,000 after buying an additional 50 shares during the period. Zions Bancorporation raised its stake in Agilent Technologies by 1.6% in the fourth quarter. Zions Bancorporation now owns 6,235 shares of the medical research company’s stock worth $284,000 after buying an additional 96 shares during the period. Stockman Wealth Management Inc. raised its stake in Agilent Technologies by 3.0% in the fourth quarter. Stockman Wealth Management Inc. now owns 5,175 shares of the medical research company’s stock worth $236,000 after buying an additional 150 shares during the period. Finally, Wetherby Asset Management Inc. raised its stake in Agilent Technologies by 3.0% in the fourth quarter. Wetherby Asset Management Inc. now owns 5,515 shares of the medical research company’s stock worth $251,000 after buying an additional 161 shares during the period.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Agilent Technologies Inc (NYSE:A) traded up 0.50% during mid-day trading on Friday, hitting $56.13. 1,654,441 shares of the stock traded hands. The stock has a 50-day moving average of $54.65 and a 200 day moving average of $49.94. The firm has a market cap of $18.09 billion, a price-to-earnings ratio of 36.00 and a beta of 1.19. Agilent Technologies Inc has a 1-year low of $41.98 and a 1-year high of $58.38.

Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, February 14th. The medical research company reported $0.53 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.04. Agilent Technologies had a return on equity of 15.49% and a net margin of 10.99%. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the company posted $0.46 EPS. Agilent Technologies’s revenue for the quarter was up 3.8% on a year-over-year basis. On average, equities analysts expect that Agilent Technologies Inc will post $2.16 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd will be paid a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Thursday, June 29th. Agilent Technologies’s dividend payout ratio (DPR) is presently 37.59%.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by BBNS and is the property of of BBNS. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://baseballnewssource.com/markets/agilent-technologies-inc-a-position-held-by-skylands-capital-llc-updated-updated-updated/635397.html.

A number of equities research analysts have issued reports on A shares. Janney Montgomery Scott increased their target price on shares of Agilent Technologies from $55.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, February 13th. Zacks Investment Research upgraded shares of Agilent Technologies from a “sell” rating to a “hold” rating in a report on Friday, February 17th. Morgan Stanley upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $62.00 price objective on the stock in a report on Wednesday, March 15th. Jefferies Group LLC restated a “buy” rating and issued a $59.00 price objective on shares of Agilent Technologies in a report on Friday, March 17th. Finally, Deutsche Bank AG restated a “buy” rating and issued a $58.00 price objective (up from $56.00) on shares of Agilent Technologies in a report on Sunday, April 2nd. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $55.46.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 32,511 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $55.48, for a total transaction of $1,803,710.28. Following the transaction, the chief executive officer now owns 260,346 shares in the company, valued at approximately $14,443,996.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $56.50, for a total value of $282,500.00. The disclosure for this sale can be found here. In the last three months, insiders sold 53,614 shares of company stock valued at $2,934,903.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

12 Month Chart for NYSE:A

Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with our FREE daily email newsletter.

 


Latest News

Zack Greinke Having Much Better Results This Season
Zack Greinke Having Much Better Results This Season
David Price and Red Sox to Meet Following Rehab Start
David Price and Red Sox to Meet Following Rehab Start
Lack of Offense Leading to Mediocrity for Boston Red Sox
Lack of Offense Leading to Mediocrity for Boston Red Sox
MLB and Facebook Announce Live Streaming for Games
MLB and Facebook Announce Live Streaming for Games
Can Anyway Stop the Houston Astros?
Can Anyway Stop the Houston Astros?
Kevin Pillar Turns from Defense to Offense
Kevin Pillar Turns from Defense to Offense


Leave a Reply

 
© 2006-2017 BBNS.